APA (7th ed.) Citation

Gelperina, S., Kisich, K., Iseman, M. D., & Heifets, L. (2005). The Potential Advantages of Nanoparticle Drug Delivery Systems in Chemotherapy of Tuberculosis. American journal of respiratory and critical care medicine, 172(12), 1487-1490. https://doi.org/10.1164/rccm.200504-613PP

Chicago Style (17th ed.) Citation

Gelperina, Svetlana, Kevin Kisich, Michael D. Iseman, and Leonid Heifets. "The Potential Advantages of Nanoparticle Drug Delivery Systems in Chemotherapy of Tuberculosis." American Journal of Respiratory and Critical Care Medicine 172, no. 12 (2005): 1487-1490. https://doi.org/10.1164/rccm.200504-613PP.

MLA (9th ed.) Citation

Gelperina, Svetlana, et al. "The Potential Advantages of Nanoparticle Drug Delivery Systems in Chemotherapy of Tuberculosis." American Journal of Respiratory and Critical Care Medicine, vol. 172, no. 12, 2005, pp. 1487-1490, https://doi.org/10.1164/rccm.200504-613PP.